Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:AAM NYSE:EQV NYSE:GMRE NASDAQ:SVII On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAAMAA Mission Acquisition$10.46$10.43$9.96▼$10.79$459.93MN/A64,921 shs40,555 shsEQVEQV Ventures Acquisition$10.43-0.5%$10.50$9.88▼$10.74$467.11MN/A123,617 shs238,382 shsGMREGlobal Medical REIT$6.49-3.9%$6.73$6.05▼$10.46$433.79M1.15612,686 shs1.47 million shsSVIISpring Valley Acquisition Corp. II$11.87-2.9%$11.79$11.12▼$12.74$117.28M-0.0421,039 shs57,131 shsBeginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAAMAA Mission Acquisition0.00%+0.19%+0.29%+1.36%+1,045,999,900.00%EQVEQV Ventures Acquisition+0.77%+0.48%-0.47%+2.64%+1,047,999,900.00%GMREGlobal Medical REIT+0.82%-4.05%-7.22%-12.05%-25.66%SVIISpring Valley Acquisition Corp. II-0.24%+2.69%+3.96%+4.49%+9.30%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAAMAA Mission AcquisitionN/AN/AN/AN/AN/AN/AN/AN/AEQVEQV Ventures AcquisitionN/AN/AN/AN/AN/AN/AN/AN/AGMREGlobal Medical REIT4.6513 of 5 stars3.33.02.53.63.42.51.3SVIISpring Valley Acquisition Corp. IIN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAAMAA Mission Acquisition 0.00N/AN/AN/AEQVEQV Ventures Acquisition 0.00N/AN/AN/AGMREGlobal Medical REIT 2.50Moderate Buy$10.4460.90% UpsideSVIISpring Valley Acquisition Corp. II 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest SVII, EQV, AAM, and GMRE Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/8/2025GMREGlobal Medical REITRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$10.00 ➝ $9.00(Data available from 8/6/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAAMAA Mission AcquisitionN/AN/AN/AN/AN/AN/AEQVEQV Ventures AcquisitionN/AN/AN/AN/AN/AN/AGMREGlobal Medical REIT$138.78M3.13$0.94 per share6.88$7.20 per share0.90SVIISpring Valley Acquisition Corp. IIN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAAMAA Mission AcquisitionN/AN/A0.00∞N/AN/AN/AN/AN/AEQVEQV Ventures AcquisitionN/AN/A0.00∞N/AN/AN/AN/AN/AGMREGlobal Medical REIT$6.63M$0.03216.317.721.145.87%1.68%0.65%N/ASVIISpring Valley Acquisition Corp. IIN/AN/A0.00∞N/AN/AN/AN/AN/ALatest SVII, EQV, AAM, and GMRE EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/7/2025Q1 2025GMREGlobal Medical REIT$0.22$0.22N/A$0.22$35.49 million$34.60 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAAMAA Mission AcquisitionN/AN/AN/AN/AN/AEQVEQV Ventures AcquisitionN/AN/AN/AN/AN/AGMREGlobal Medical REIT$0.609.25%N/A2,000.00%N/ASVIISpring Valley Acquisition Corp. IIN/AN/AN/AN/AN/ALatest SVII, EQV, AAM, and GMRE DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/28/2025GMREGlobal Medical REITquarterly$0.159.47%6/20/20257/9/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAAMAA Mission AcquisitionN/AN/AN/AEQVEQV Ventures AcquisitionN/AN/AN/AGMREGlobal Medical REIT1.440.260.26SVIISpring Valley Acquisition Corp. IIN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAAMAA Mission AcquisitionN/AEQVEQV Ventures AcquisitionN/AGMREGlobal Medical REIT57.52%SVIISpring Valley Acquisition Corp. II89.78%Insider OwnershipCompanyInsider OwnershipAAMAA Mission AcquisitionN/AEQVEQV Ventures AcquisitionN/AGMREGlobal Medical REIT8.50%SVIISpring Valley Acquisition Corp. II0.54%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAAMAA Mission AcquisitionN/A43.97 millionN/AN/AEQVEQV Ventures AcquisitionN/A44.57 millionN/AN/AGMREGlobal Medical REIT3066.87 million61.19 millionOptionableSVIISpring Valley Acquisition Corp. IIN/A9.88 million9.83 millionNot OptionableSVII, EQV, AAM, and GMRE HeadlinesRecent News About These CompaniesSpring Valley Acquisition Corp. II (NASDAQ:SVII) Short Interest UpdateJuly 30, 2025 | marketbeat.comSpring Valley Acquisition Corp. II (NASDAQ:SVII) Stock Price Down 0.5% - Time to Sell?July 16, 2025 | marketbeat.comSpring Valley Acquisition Corp II Ordinary Shares - Class A SVIIJuly 2, 2025 | morningstar.comM(SVII) Long Term Investment AnalysisFebruary 2, 2025 | news.stocktradersdaily.comNWhen the Price of (SVII) Talks, People ListenJanuary 12, 2025 | news.stocktradersdaily.comNSpring Valley Acquisition Corp II (SVII) Stock: More Strategic Than Meets the EyeOctober 23, 2024 | bovnews.comBSVII Spring Valley Acquisition Corp. IIAugust 9, 2024 | seekingalpha.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeSVII, EQV, AAM, and GMRE Company DescriptionsAA Mission Acquisition NYSE:AAM$10.46 0.00 (0.00%) As of 03:27 PM EasternAA Mission Acquisition Corp. engages in the acquisition and merge of companies. It was founded on February 9, 2024 and is headquartered in The Woodlands, TX.EQV Ventures Acquisition NYSE:EQV$10.43 -0.05 (-0.48%) As of 03:55 PM EasternEQV Ventures Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The company was founded on April 15, 2024 and is headquartered in Park City, UT.Global Medical REIT NYSE:GMRE$6.49 -0.26 (-3.90%) Closing price 03:59 PM EasternExtended Trading$6.50 +0.02 (+0.28%) As of 06:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Global Medical REIT Inc. (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.Spring Valley Acquisition Corp. II NASDAQ:SVII$11.87 -0.35 (-2.86%) Closing price 03:59 PM EasternExtended Trading$12.01 +0.14 (+1.21%) As of 05:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Spring Valley Acquisition Corp. II does not have significant operations. It intends effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination. The company was incorporated in 2021 and is based in Dallas, Texas. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Joby Deal Gives Blade New Direction, But Stock Lacks Lift How DigitalOcean's Focus Is Fueling Explosive Growth Disney’s Iger-Led Turnaround Gains Traction Can Celsius Stock Keep Its Momentum Going Any Longer? AMD’s Results Sparked a Sell-Off—But That’s Your Buy Signal Rivian Takes Earnings Hit—R2 Could Be the Stock's 2026 Lifeline Does Broadcom Have a VMware Problem? Goldman Eyes Upside in NTNX Up Nearly 300% in 2 Years, It’s Not Too Late to Buy Mercado Libre Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
